1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with salicylates in 1 studies
| Studies (1-methyl-4-phenyl-2,3-dihydropyridinium) | Trials (1-methyl-4-phenyl-2,3-dihydropyridinium) | Recent Studies (post-2010) (1-methyl-4-phenyl-2,3-dihydropyridinium) | Studies (salicylates) | Trials (salicylates) | Recent Studies (post-2010) (salicylates) |
|---|---|---|---|---|---|
| 46 | 0 | 3 | 13,317 | 853 | 1,678 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiueh, CC; Obata, T | 1 |
1 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and salicylates
| Article | Year |
|---|---|
In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dialysis; Dopamine; Free Radicals; Hydroxides; Hydroxyl Radical; Male; Nerve Endings; Perfusion; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Salicylic Acid; Substantia Nigra | 1992 |